Literature DB >> 17848574

MDM2 chaperones the p53 tumor suppressor.

Bartosz Wawrzynow1, Alicja Zylicz, Maura Wallace, Ted Hupp, Maciej Zylicz.   

Abstract

The murine double minute (mdm2) gene encodes an E3 ubiquitin ligase that plays a key role in the degradation of p53 tumor suppressor protein. Nevertheless recent data highlight other p53-independent functions of MDM2. Given that MDM2 protein binds ATP, can interact with the Hsp90 chaperone, plays a role in the modulation of transcription factors and protection and activation of DNA polymerases, and is involved in ribosome assembly and nascent p53 protein biosynthesis, we have evaluated and found MDM2 protein to possess an intrinsic molecular chaperone activity. MDM2 can substitute for the Hsp90 molecular chaperone in promoting binding of p53 to the p21-derived promoter sequence. This reaction is driven by recycling of MDM2 from the p53 complex, triggered by binding of ATP to MDM2. The ATP binding mutant MDM2 protein (K454A) lacks the chaperone activity both in vivo and in vitro. Mdm2 cotransfected in the H1299 cell line with wild-type p53 stimulates efficient p53 folding in vivo but at the same time accelerates the degradation of p53. MDM2 in which one of the Zn(2+) coordinating residues is mutated (C478S or C464A) blocks degradation but enhances folding of p53. This is the first demonstration that MDM2 possesses an intrinsic molecular chaperone activity, indicating that the ATP binding function of MDM2 can mediate its chaperone function toward the p53 tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848574     DOI: 10.1074/jbc.M702767200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  p53 and MDM2 are involved in the regulation of osteocalcin gene expression.

Authors:  Hankui Chen; Kevin Kolman; Natalie Lanciloti; Michael Nerney; Emily Hays; Chet Robson; Nalini Chandar
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.

Authors:  Bartosz Wawrzynow; Susanne Pettersson; Alicja Zylicz; Janice Bramham; Erin Worrall; Ted R Hupp; Kathryn L Ball
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

3.  Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.

Authors:  Erin G Worrall; Bartosz Wawrzynow; Liam Worrall; Malcolm Walkinshaw; Kathryn L Ball; Ted R Hupp
Journal:  J Chem Biol       Date:  2009-05-16

4.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

5.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

6.  Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.

Authors:  Anand Ponnuswamy; Ted Hupp; Robin Fåhraeus
Journal:  Genes Cancer       Date:  2012-03

7.  Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome.

Authors:  Gunter Assmann; Annette D Wagner; Mueller Monika; Claudia Pfoehler; Michael Pfreundschuh; Wolfgang Tilgen; Klaus Roemer
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

8.  14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer.

Authors:  Bing Wang; Kang Liu; Hui-Yi Lin; Naresh Bellam; Shiyun Ling; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

9.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.